Toll Free: 1-888-928-9744

InteRNA Technologies B.V. - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

InteRNA Technologies B.V. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'InteRNA Technologies B.V. - Product Pipeline Review - 2014', provides an overview of the InteRNA Technologies B.V.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of InteRNA Technologies B.V.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of InteRNA Technologies B.V. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of InteRNA Technologies B.V.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the InteRNA Technologies B.V.'s pipeline products

Reasons to buy

- Evaluate InteRNA Technologies B.V.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of InteRNA Technologies B.V. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the InteRNA Technologies B.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of InteRNA Technologies B.V. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of InteRNA Technologies B.V.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of InteRNA Technologies B.V. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
InteRNA Technologies B.V. Snapshot 4
InteRNA Technologies B.V. Overview 4
Key Information 4
Key Facts 4
InteRNA Technologies B.V. - Research and Development Overview 5
Key Therapeutic Areas 5
InteRNA Technologies B.V. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
InteRNA Technologies B.V. - Pipeline Products Glance 11
InteRNA Technologies B.V. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
InteRNA Technologies B.V. - Drug Profiles 13
MicroRNA for GBM and Renal Cell cancer 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
miRNA-3157 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
MicroRNA to Inhibit Mutated Ataxia Telangiectasia Gene for Head and Neck Cancer 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
MicroRNAs for Neurodegenerative Diseases 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
miRNA for Cancer 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
InteRNA Technologies B.V. - Pipeline Analysis 19
InteRNA Technologies B.V. - Pipeline Products by Target 19
InteRNA Technologies B.V. - Pipeline Products by Molecule Type 20
InteRNA Technologies B.V. - Pipeline Products by Mechanism of Action 21
InteRNA Technologies B.V. - Recent Pipeline Updates 22
InteRNA Technologies B.V. - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25
List of Tables
InteRNA Technologies B.V., Key Information 4
InteRNA Technologies B.V., Key Facts 4
InteRNA Technologies B.V. - Pipeline by Indication, 2014 6
InteRNA Technologies B.V. - Pipeline by Stage of Development, 2014 7
InteRNA Technologies B.V. - Monotherapy Products in Pipeline, 2014 8
InteRNA Technologies B.V. - Partnered Products in Pipeline, 2014 9
InteRNA Technologies B.V. - Partnered Products/ Combination Treatment Modalities, 2014 10
InteRNA Technologies B.V. - Preclinical, 2014 11
InteRNA Technologies B.V. - Discovery, 2014 12
InteRNA Technologies B.V. - Pipeline by Target, 2014 19
InteRNA Technologies B.V. - Pipeline by Molecule Type, 2014 20
InteRNA Technologies B.V. - Pipeline Products by Mechanism of Action, 2014 21
InteRNA Technologies B.V. - Recent Pipeline Updates, 2014 22
InteRNA Technologies B.V., Other Locations 23 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify